Ausgabe 3/2015
Inhalt (17 Artikel)
Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead
- Health Economics (N Khera, Section Editor)
Christa Krupski, Madan Jagasia
Persistent Disparities in Adult Hematopoietic Cell Transplantation
- Health Economics (N Khera, Section Editor)
David G. Crockett, Fausto R. Loberiza Jr
Optimizing Quality and Efficiency of Healthcare Delivery in Hematopoietic Cell Transplantation
- Health Economics (N Khera, Section Editor)
Navneet S Majhail
Financial Hardship—an Unwanted Consequence of Cancer Treatment
- Health Economics (N Khera, Section Editor)
Julie McNulty, Nandita Khera
The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology
- Health Economics (N Khera, Section Editor)
Hemant S. Murthy, William A. Wood
A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies
- Health Economics (N Khera, Section Editor)
Marlise R. Luskin, Rahul Banerjee, Sarah Del Percio, Alison W. Loren
Non-Hodgkin Lymphoma in Children
- B-cell NHL, T-cell NHL and Hodgkin Lymphoma (J Armitage, Section Editor)
John T. Sandlund
To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes
- B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Armitage, Section Editor)
Jean L. Koff, Dai Chihara, Anh Phan, Loretta J. Nastoupil, Jessica N. Williams, Christopher R. Flowers
The GHSG Approach to Treating Hodgkin’s Lymphoma
- B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Armitage, Section Editor)
Paul J. Bröckelmann, Andreas Engert
Treating Burkitt Lymphoma in Adults
- B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Armitage, Section Editor)
Carla Casulo, Jonathan Friedberg
Incidence and Burden of the Myelodysplastic Syndromes
- Open Access
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Christopher R. Cogle
Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?
- Open Access
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Rafael Bejar
Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Kristen B. McCullough, Mrinal M. Patnaik
Where Does Lenalidomide Fit in Non-del(5q) MDS?
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Aristoteles Giagounidis
Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Anna Porwit
Outlook and Management of Patients with Myelodysplastic Syndromes Failed by Hypomethylating Agents
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Daniel A. Roberts, David P. Steensma
Preparing Patients With Myelodysplastic Syndrome for Transplant When Is Pre-transplant Cytoreductive Therapy Appropriate?
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Martin Wermke, Silke Gloaguen, Uwe Platzbecker
